Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating transcription factor 2 (ATF2) is a member of the leucine zipper family of transcription factors, encoded by the ATF2 gene in humans. It binds to cAMP-responsive elements (CRE) in DNA and can form homodimers or heterodimers, notably with c-Jun. ATF2 also acts as a histone acetyltransferase, specifically acetylating histones H2B and H4, which influences chromatin structure and transcriptional activation. The protein is activated by stress signals such as those mediated by the p38 and JNK MAP kinases, and by the DNA damage response via ATM-dependent phosphorylation. ATF2 plays diverse roles in regulating cell growth, apoptosis, DNA repair, and development, and can contribute to both oncogenesis and tumor suppression depending on cellular context. Dysregulation of ATF2 impacts several human diseases, including cancer and cardiomyopathies.
Modulation of CRE-dependent transcription via dimerization or phosphorylation; Alteration of chromatin state through histone acetylation; Regulation of apoptotic pathways and DNA damage response
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating transcription factor 2 (ATF2).